Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort.

Pascal Juillerat , Harry Sokol (1, 2) , Florian Froehlich , Vijay Yajnik , Laurent Beaugerie (2, 1) , Matthew Lucci (3) , Bernard Burnand , Andrew J Macpherson (4) , Jacques Cosnes (2) , Joshua R Korzenik

1 CHU Saint-Antoine [AP-HP]
2 UPMC - Université Pierre et Marie Curie - Paris 6
3 Departamento de Historia Moderna y Contemporánea
4 CERN - European Organization for Nuclear Research

Domaines: Chimie organique

Pascal Juillerat, Harry Sokol, Florian Froehlich, Vijay Yajnik, Laurent Beaugerie, et al.. Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort.. Inflammatory Bowel Diseases, 2014, 21 (1), pp.60-70. ⟨10.1097/MIB.0000000000000225⟩. ⟨hal-01097180⟩